| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |